Headquartered in Louisville, KY Fiscal year ends December NYSE: HUM humana.com
Humana Inc. (NYSE: HUM) is a U.S. healthcare company operating through two primary segments: Insurance and CenterWell. The Insurance segment offers Medicare Advantage (individual and group), Medicare stand-alone prescription drug plans (PDP), state-based Medicaid managed care contracts, specialty benefits (dental, vision, supplemental), Medicare Supplement plans, and pharmacy benefit management (PBM) services. The CenterWell segment provides healthcare delivery services including senior-focused primary care clinics (398 centers serving 622,000 patients), pharmacy solutions (mail-order and specialty pharmacy with industry-leading mail order penetration), and home health services. Humana serves millions of Medicare and Medicaid beneficiaries, military service personnel through TRICARE-related contracts, and individuals/employers. The company pursues an integrated care delivery model designed to improve health outcomes while managing costs, with a growing payor-agnostic strategy in its CenterWell business. Humana's revenue is heavily concentrated in Medicare products, making it particularly sensitive to CMS benchmark funding rates, Star Ratings quality bonus payments, and regulatory changes such as the Inflation Reduction Act and the v28 risk model revision. Updated
Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that…
Gerelyn Terzo UnitedHealth shareholders spent five years waiting for a stock that barely budged, yet something inside the company kept growing the whole time. Whether that something is enough to make UNH worth holding…
A fresh analyst upgrade is sending Humana (NYSE:HUM | HUM Price Prediction) shares sharply higher, and the rally stands apart from a quiet managed care group. Humana stock is up 7% to…
Humana is exiting plans and counting on hundreds of thousands of affected members to land back inside the company. Before you accept what arrives in that envelope this fall, there are four…
Gerelyn Terzo TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped…
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a…
Humana's non-renewal letters are already in the mail, and the deadline to act is closer than most affected members realize. Missing it by even one day changes what coverage options remain available…
Gerelyn Terzo A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the…
AJ Tiarsmith A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.
Gerelyn Terzo Every September, Medicare plans mail a document most enrollees skim past without realizing the page after the premium notice can quietly rewrite their entire healthcare budget for the coming year.
Gerelyn Terzo Joel Greenblatt built Gotham Asset Management on concentrated value bets, so his latest 13F filing caught analysts off guard with moves that look less like a stock-picker's conviction and more like someone…
A Humana termination letter looks like bad news, but it quietly unlocks a set of rights most members never knew they had, and those rights expire on a clock most people never…
Gerelyn Terzo Wall Street analysts reshuffled their ratings on Wednesday, sending some familiar names higher while punishing others with sharp target cuts. Find out which stocks got surprise upgrades and which ones analysts are…
Millions of Medicare Advantage members will open a letter this fall that could quietly close doors they assume will always stay open. What insurers have already decided for 2027 and what enrollees…
Wall Street analysts reshuffled their bets on Thursday as geopolitical fires, a Fed dissent surprise, and a brutal semiconductor selloff forced some major rating reversals across insurance, gaming, tech, and energy stocks.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company operating through two primary segments: Insurance and CenterWell.
24/7 Wall St.'s 12-month price target for HUM is $480.75, rated Buy. The Wall Street consensus target is $423.74. HUM price prediction →
